stockrowTenet Healthcare Corporation
THC Healthcare Medical Care Facilities
Tenet Healthcare Corporation’s revenue for fiscal 2025 (year ended December 2025) was $21.3 billion, up 3.07% from fiscal 2024.
- Revenue
- +6.47%
- EPS
- +291.1%
- Free cash flow
- +39.2%
- Total debt
- +0.42%
Quarter to September 2026, against a year earlier
Follow THC
Alert me
Tenet Healthcare Corporation (THC) EBITDA
Tenet Healthcare Corporation's EBITDA for fiscal 2025 was $4.4B, down 35.4% from $6.8B in fiscal 2024. Over the twelve months to 30 September 2026 it was $7.1B. Over the past ten years it has ranged from $1.9B (fiscal 2015) to $6.8B (fiscal 2024); the current reading is higher than 91% of that period. Tenet Healthcare Corporation ranks 2nd of 48 Medical Care Facilities companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | $4.4B | (35.38%) |
| FY2024 | $6.8B | 99.30% |
| FY2023 | $3.4B | 6.39% |
| FY2022 | $3.2B | (14.68%) |
| FY2021 | $3.8B | 30.34% |
| FY2020 | $2.9B | 19.08% |
| FY2019 | $2.4B | (2.50%) |
| FY2018 | $2.5B | 22.55% |
| FY2017 | $2.0B | (5.19%) |
| FY2016 | $2.1B | 11.64% |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Sep 2026 | $2.0B | (7.63%) |
| Jun 2026 | $2.1B | 9.88% |
| Mar 2026 | $1.9B | 78.42% |
| Dec 2025 | $1.1B | (2.16%) |
| 43 more quarters | Free account |
Against its own ten years
EBITDA against peers
| Company | EBITDA |
|---|---|
| THC Tenet Healthcare Corporation | $7.1B |
| FMS Fresenius Medical Care AG & Co. KGaA compare | $3.8B |
| DVA DaVita Inc. compare | $2.8B |
| UHS Universal Health Services, Inc. compare | $2.7B |
| EHC Encompass Health Corporation compare | $1.5B |
| ENSG The Ensign Group, Inc. compare | $630.9M |
| PACS PACS Group, Inc. compare | $500.6M |
| CON Concentra Group Holdings Parent, Inc. compare | $479.6M |
| CHE Chemed Corporation compare | $438.8M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on THC
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement